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Abstract
Double chromodomains occur in CHD proteins which are ATP-dependent chromatin remodeling
factors implicated in RNA polymerase II transcription regulation. Biochemical studies suggest
important differences in the histone H3 tail binding of different CHD chromodomains. In human and
Drosophila, CHD1 double chromodomains bind lysine 4-methylated histone H3 tail which is a
hallmark of transcriptionally active chromatin in all eukaryotes. Here, we present the crystal structure
of the yeast CHD1 double chromodomains, and pinpoint its differences with that of the human CHD1
double chromodomains. The most conserved residues in these double chromodomains are the two
chromoboxes that orient adjacently. Only a subset of CHD chromoboxes can form an aromatic cage
for methyllysine binding, and methyllysine binding requires correctly oriented inserts. These factors
preclude yeast CHD1 double chromodomains to interact with the histone H3 tail. Despite great
sequence similarity between the human CHD1 and CHD2 chromodomains, variation within an insert
likely prevents CHD2 double chromodomains to bind lysine 4-methylated histone H3 tail as
efficiently as in CHD1. By using the available structural and biochemical data we highlight the
evolutionary specialization of CHD double chromodomains, and provide insights about their
targeting capacities.
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Introduction
CHD (chromo-ATPase/helicase-DNA-binding) proteins are uniquely structured to encode
double chromodomains, and these domains always occur N-terminal to a conserved SNF2
domain (Figure 1) 1. A recent review discusses how multiple subfamilies of SNF2-containing
proteins, found in eukaryotes, may perform ATP-dependent protein translocation on DNA, and
promote chromatin remodeling 2. In vitro studies have shown purified CHD1 proteins from
Saccharomyces and Drosophila to exhibit ATP-dependent nucleosome repositioning to
organize oligonucleosomes in a structure that is compatible with gene expression during
transcription 3; 4. All SNF2 containing proteins and their complexes contain other conserved
domains that are expected to influence their repertoire of chromatin remodeling functions by
Corresponding author: Sepideh Khorasanizadeh E-mail: khorasan@virginia.edu Phone: (434) 243-4817 Fax: (434) 924-5069.
Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers
we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting
proof before it is published in its final citable form. Please note that during the production process errors may be discovered which could
affect the content, and all legal disclaimers that apply to the journal pertain.
Accession Number: The coordinates have been deposited in the Protein Data Bank under ID code 2H1E.
NIH Public Access
Author Manuscript
J Mol Biol. Author manuscript; available in PMC 2007 August 14.
Published in final edited form as:













forming specific protein-protein and protein-DNA contacts. In vertebrates, nine CHD variants
contribute to the regulation of transcription, whereas Saccharomyces yeast encodes one CHD
protein. Yet, molecular differences between distinct CHD proteins and their chromatin
targeting potentials are poorly understood 5. It is necessary to understand the structure and
sequence differences among CHD proteins to establish a better understanding of their
interaction and chromatin remodeling potentials.
A simplistic classification of CHD proteins based on their conserved domain organization
suggests these proteins can be clustered into three classes as shown in Figure 1. For example,
all CHD genes from unicellular organisms are similar to human CHD1, and distinct from two
other classes that are encoded in multi-cellular organisms; these are represented by human
CHD4 and human CHD7 genes in Figure 1. Human CHD3 and CHD4 integrate within multi-
subunit complexes termed NuRD (nucleosome remodeling histone deacetylase; for review see;
6; 7; 8), and human CHD7 regulates differentiation and development of several organs 9; 10.
Genetic studies have shown that Saccharomyces CHD1 is present at transcribed genes, and its
chromodomains are essential for this function 11. Although regions of transcribed genes in all
eukaryotes are rich in lysine 4 methylation on the histone H3 tail (H3K4me), neither the
chromodomains nor the intact Saccharomyces CHD1 protein interacts with the H3K4me
peptide 12; 13; 14; 15.
This is in stark contrast with the specific mode of interaction we previously identified and
characterized for binding of the human CHD1 to the H3K4me peptide. To better understand
the molecular features of the CHD1 double chromodomains, we have determined the atomic
structure of this region in Saccharomyces CHD1 to delineate its differences with the human
CHD1 structure. We have also generated a phylogenetic tree of CHD proteins based on their
chromodomain segments, which suggests distinct functional specialization during evolution.
We show 21-residue chromoboxes form the conserved core in each chromodomain of all CHD
proteins, and propose diversity is generated by distinct insert regions outside the chromobox
sequences. As the targets of the majority of CHD double chromodomains, including
Saccharomyces CHD1, remain unidentified, our analysis offers a practical guide to further
investigate the targeting and contribution of the chromodomain region to the function of the
CHD proteins.
Results and Discussion
Differences between human and yeast CHD1
To explain the observed functional differences between human and yeast CHD1
chromodomains, we solved the crystal structure of the Saccharomyces CHD1 double
chromodomains at 2.2 Å resolution (Table 1). Figure 2 shows this structure in comparison
with that of the human CHD1 in complex with the methylated histone H3 tail. In both structures,
each set of the secondary structure elements corresponding to a chromodomain assembles
similar to the prototypical HP1 chromodomain 13. However, sequence insertions in between
the conserved regions in chromodomain 1 lead to a substantially larger chromodomain. A
universal insert in CHD chromodomain 1 is insert 2, which serves to block peptide binding as
seen in HP1 and Polycomb chromodomains 13. The CHD double chromodomains arrange
perpendicular to each other using a helical linker. Interestingly, the inter-chromodomain linker
segments of Saccharomyces CHD1 and human CHD1 exhibit only 18% sequence identity, but
both use 33 residues to fold similarly (Figure 2C). The structure of Saccharomyces CHD1
suggests chromodomains 1 and 2 may also cooperate to bind a partner.
Human and Saccharomyces CHD1 exhibit a major difference in the folding of their insert 1
region within chromodomain 1 (Figure 2). In Saccharomyces, insert 1 folds adjacent to the
α2 region. Interestingly, two unconserved cysteine residues in insert 1 and α2 face each other
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at a distance compatible with a disulfide bond, and this could further stabilize the close
positioning of insert 1 to α2 only in Saccharomyces CHD1. These features in chromodomain
1 of Saccharomyces CHD1 have also been noted in the recently reported solution structure of
this domain 15. Unlike in Saccharomyces, human insert 1 forms the inter-chromodomain
surface, and directly contributes to the histone H3 tail binding 13. Additionally, in human
CHD1, two tryptophans (322 and 325) in chromodomain 1 form an aromatic cage around
methyllysine 4 of the H3 tail (Figure 2B) 13. In Saccharomyces CHD1, there is a substitution
of the second tryptophan with a Glu. To determine if Glu replacement with a Trp would impart
methyllysine binding to Saccharomyces CHD1, we performed mutagenesis in conjunction with
fluorescence anisotropy binding studies.
Figure 3c shows that the mutant Saccharomyces CHD1 E220W does not interact with the lysine
4 methylated histone H3 tail, suggesting that differences in other regions, particularly the
folding of insert 1 dramatically affect binding capacities of CHD1 proteins. To date, a specific
binding partner for Saccharomyces CHD1 double chromodomains has not been reported, but
hints about such partners are revealed from interactome studies. Saccharomyces CHD1 has
been identified in complexes with casein kinase II as well as a group of proteins that facilitate
elongation for transcription by RNA polymerase II 16; 17. It is likely that the double
chromodomains of Saccharomyces cooperate to accommodate binding of a protein partner at
the juncture of chromodomains.
Structure of the Chromobox Homology Region
An alignment of the sequences of all CHD variants with non-CHD chromodomains reveals
their most conserved region is limited to 21 residues that forms a conserved core in each
chromodomain (Figure 3A,B and supplementary figure S1). We reintroduce the term
chromobox to refer to this homology region. Originally the term chromobox was used to imply
the nucleotide sequence that encodes 37 homologous amino acids in the chromodomains of
HP1 and Polycomb genes 18. The 21-residue chromobox in CHD1 proteins is highly related
in structure to that region in HP1 and Polycomb proteins 13. When aromatic residues are present
at both positions 5 and 8 of the chromobox then formation of a two-residue aromatic cage for
binding a methyllysine is predicted (Figures 2, 3b, and supplementary figure S1). We note that
human CHD1 chromobox 1 meets this requirement, whereas neither human CHD1 chromobox
2 nor Saccharomyces CHD1 chromoboxes meets this requirement. The CHD chromoboxes
form highly related structures due to significant sequence identity; there is 33% sequence
identity between chromoboxes 1 and 2 in Saccharomyces CHD1. Also, the human and
Saccharomyces CHD1 proteins have 62% identity in chromobox 1 and 43% sequence identity
in chromobox 2 regions. Figure 3B shows that the absolutely conserved Tyr 10 in chromobox
2 could not cooperate with Trp 5 to form a novel aromatic cage as was predicted in a study that
showed chromodomain 2 in Saccharomyces CHD1 binds lysine-4 methylated H3 tail 19.
Therefore, Saccharomyces CHD1, and highly likely, any other CHD protein could not use the
chromodomain 2 region to assemble an aromatic cage for interaction with a lysine-methylated
peptide.
Phylogenetic Classification of CHD Proteins According to Chromodomains
To understand the relationship among the diverse CHD proteins, we prepared a phylogenetic
tree on the basis of their aligned chromodomain sequences (Figure 4). A total of 34 CHD
proteins were included in our sequence alignment. We observed distinct patterns of similarities
that suggest the presence of major evolutionary divisions in CHD proteins. This led to a clear
split among CHD1 proteins where we found those from unicellular organisms to form a
separate group (class B) from the CHD1 proteins of multi-cellular organisms (class A).
Therefore, H3K4me binding is widely used in class A. Interestingly, in vertebrates, a CHD2
gene also belongs to class A that exhibits high sequence identity with human CHD1 (Figures
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2C and 4). We noted a difference in the insert 3 region in chromodomain 2, as this region is
15 residues longer in CHD2 and likely interferes with peptide binding surface. To determine
whether changes in insert 3 influence target selectivity, we prepared the double chromodomain
fragment of human CHD2, and performed fluorescence anisotropy binding assays with
methylated histone peptides. Figure 3c shows human CHD2 interacts with the H3K4me peptide
30-fold weaker than that detected for human CHD1. Furthermore, the presence of lysine 9
acetylation, arginine 2 methylation or lysine 36 methylation does not improve the binding
affinity of human CHD2 for H3K4me peptide. While the biochemical function of CHD2 is
unknown, mouse CHD2 gene is shown to have a role in development and survival 20.
Therefore, we suggest an important role for insert 3 extension is to regulate H3K4me binding
by CHD2 protein in a manner coordinated with complex stages of transcription. One possible
mechanism may involve the action of a temporally regulated kinase that phosphorylates CHD2
to relieve insert 3 interference with histone tail binding.
The organisms listed in class B encode one CHD protein, except in Schizosaccharomyces where
there are two CHD proteins called HRP1 and HRP3 (Figure 4). The double chromodomains
of HRP1 and HRP3 are highly related to each other, yet HRP3 chromodomain 1 has aromatic
residues at both positions 5 and 8 of the chromobox. Interestingly, the insert 1 region in both
HRP proteins is shorter than that in Saccharomyces CHD1, suggesting although HRP3 may
bind a lysine-methylated peptide the contribution of insert 1 to binding may be distinct from
that used by human CHD1 (Figure 1B, and supplementary Figure S1).
Distinct from the two CHD1 classes is class C CHDs that includes CHD3 through CHD5,
sometimes referred to as Mi-2 proteins (Figures 4 and supplementary Figure S1). These CHDs
typically reside in multisubunit NuRD complexes, and contribute to histone deacetylation (for
review see; 6). Chromodomain 1 in this class always contains a hydrophobic residue at position
8 of the chromobox, precluding a methyllysine binding function via an aromatic cage. The
inter-chromodomain linker is 10 residues longer than that in CHD1 proteins (supplementary
Figure S1), suggesting an altered organization of the tandem chromodomains. The
chromodomains of Drosophila Mi-2 are shown not to interact with methylated H3 tail, and
instead are implicated in DNA binding that is required for nucleosome recognition 21. The
structure or affinity of such DNA binding is not yet determined, and DNA binding does not
appear to be the function of CHD1 chromodomains, as we did not detect it for
Saccharomyces CHD1 and human CHD1 (data not shown). Furthermore, in contrast to the
inter-chromodomain linker in CHD1, class C linkers contain substantially more lysines and
arginine residues, indicating a potential for using a unique surface of interaction for DNA
binding. Interestingly, majority of class C CHDs contain two PHD fingers that always occur
N-terminal to the double chromodomains (Figure 1). The PHD finger has also been implicated
in lysine-methylated histone tail binding involving an aromatic cage 22; 23; 24. A CHD3 PHD
finger was recently shown to bind H3K36me peptide using a pull down assay 23. It remains
to be shown whether PHD fingers and class C chromodomains can cooperate to form a unique
interaction with nucleosomes.
Another subfamily is class D that includes CHD7 (Figures 1 and 4), which is implicated in the
CHARGE syndrome. CHARGE syndrome is a common cause of congenital anomalies
affecting several tissues in humans. Mutations in the CHD7 gene of individuals with the
CHARGE syndrome are believed to account for the disease 25. More recently the phenotypic
spectrum of human mutations along CHD7 gene, including those in the chromodomain region,
has been reported for patients with CHARGE syndrome 26. Other members of class D also
appear to contribute to tissue and developmentally specific chromatin regulation. For example,
CHD8 (or Duplin) is associated with beta catenin-mediated gene expression 27; 28, whereas
CHD9 is associated with ligand-dependent transcription by nuclear receptors 29. Class D
CHDs contains chromodomains with different aromatic residues at positions 5 and 8 of
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chromobox 1 (Tyr at position 5 and a Phe/Tyr at position 8; see Figures 3a). They also exhibit
very long insert 1 regions, suggesting class D may form an aromatic cage to bind methyllysine
at the juncture of the two chromodomains (supplementary Figure S1A). Interestingly, this class
exhibits an inter-chromodomain linker that is 13 residues shorter than the one in A and B classes
(supplementary Figure S1B). Additional studies are necessary to determine whether reducing
the linker impacts the tandem chromodomain arrangement and lead to new surfaces of inter-
molecular interaction.
Finally, found four CHD proteins that exhibit dramatic divergence in their double
chromodomain sequences. As such their evolutionary order of appearance could not be judged
by our analysis. These are represented by two uncharacterized members from Arabidopsis, one
from Giardia lamblia and one from Plasmodium falciparum (Figure 4). Giardia lamblia causes
gastroenteritis in mammals, manifesting itself with severe diarrhea and abdominal cramps in
humans. Plasmodium falciparum causes malaria, which is considered a major threat to human
populations. The analysis of single nucleotide polymorphism for Plasmodium falciparum has
previously revealed the divergence time for this organism to coincide with the start of human
population expansion and consistent with a genetically complex organism able to evade host
immunity 30. Despite dramatic sequence differences in the CHDs of Plasmodium and
Giardia, their two chromoboxes are highly conserved as shown in Figure 3a. Moreover, the
organization of conserved domains in both of these CHD proteins resembles that of CHD1
(Figure 1), suggesting they have a fundamental role in transcription regulation. As with
Saccharomyces CHD1, Plasmodium and Giardia CHD proteins do not have the necessary
combination of aromatic residues to bind a lysine-methylated peptide (Figure 3A).
Conclusion
In vitro studies have demonstrated that Drosophila CHD1 can act alone to organize nucleosome
arrays in a form that is compatible with chromatin during transcription (i.e., a larger inter-
nucleosome spacing and lack of incorporation of the linker histone H1) 4. During transcription
by RNA polymerase II, nucleosomes do not fall apart, but instead become displaced in a
carefully regulated manner to comply with initiation, elongation and termination stages (for
review see; 31). We suggest CHD proteins manage nucleosome repositioning at various stages
of transcription by responding to important epigenetic queues. We suspect the double
chromodomains of CHD proteins assist this process and help to organize distinct CHD proteins
at various sites of gene activity. While some unicellular organisms have only one class of CHD
proteins, in worms, flies, plants and vertebrates, three distinct classes exist and all are
implicated in transcription regulation. For class A CHDs we indicated their localization
involves binding of their double chromodomains to the lysine 4 methylated H3 tail (for review
see; 32). This modification typically correlates with transcription start sites as well as
throughout the coding regions. Class C CHDs may use PHD fingers to recognize the lysine 36
methylated H3 tail, and use double chromodomains for DNA binding 21; 23. The H3K36me
modification is also associated with transcription. As class C CHDs are components of histone
deacetylating complexes, they may be related to the Rpd3S histone deactylating complex that
has been shown to localize at transcription termination sites in Saccharomyces. Within Rpd3S,
a chromodomain protein called Eaf3 recognizes the H3K36me modification 33; 34.
Class D CHDs have double chromodomains that appear to recognize a protein partner bearing
a methyllysine. In Drosophila, both CHD1 and Kismet-L facilitate transcription by RNA
polymerase II 35; 36. Localizations of CHD1 and Kismet-L are distinct during transcription
stages, and Kismet-L populates transcription sites prior to CHD1 arrival 36. Mammalian CHD6
is also shown to co-localize with RNA polymerase II during both preinitiation and elongation
stages of transcription 37. Additional studies are required to understand the molecular
mechanism(s) that various CHD proteins exert to prepare chromatin for RNA polymerase II
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action. This is likely to be very important for the understanding of the basic transcription
apparatus as well as the more complex tissue and cell specific gene transcription in multi-
cellular organisms.
The appropriate mode of CHD localization to transcription sites appears to have dramatic
consequences as mutations in CHD7 protein, that are implicated in the CHARGE syndrome,
often lead to premature stop codons 26. Furthermore, malaria and Giardia parasites encode
substantially different CHD proteins. For Plasmodium falciparum the complete genome is
characterized and annotated 38. Moreover, the protein interaction network within malaria has
been extensively studied, and resulted in identifying potential partners for the malaria CHD
protein 39. Interestingly, a recent report indicated that dual infection with HIV and malaria
fuels the spread of both diseases, and these diseases together cause the deaths of over 4 million
people per year in Africa 40. The chromatin machinery of malaria likely contributes to this
factor as malaria, which is not sexually transmitted, has dramatically impacted the process of
spreading HIV infection.
Materials and Methods
Cloning and protein purification
All expression constructs contain an N-terminal 6xHis-tag, were cloned into the BamHI/NdeI
sites of the pET11a vector, expressed in BL21(DE3) E. coli (Novagen), and purified by Ni2+-
affinity chromatography (Qiagen). The double chromodomain constructs express residues
174-339 (for Saccharomyces CHD1) and residues 257-447 (for human CHD2) of the
corresponding CHD genes. The E220W point mutation in Saccharomyces CHD1 was prepared
using the QuikChange mutagenesis kit (Stratagene).
Binding assays
For fluorescence polarization, 100 nM of fluorescein-labelled peptide (prepared and used as
previously described 41) was used in 50 mM sodium phosphate pH 8.0, 25 mM NaCl, 5 mM
TCEP (the binding assays involving human CHD2 contained an additional 25 mM NaCl). The
peptides used in binding assays were H3K4me3 [ARTK(me3)QTARKSTGGKAY],
H3K36me3 [APSTGGVK(Me3)KPHRY], H3K4me3K9acK14acK18ac [ARTK(me3)
QTARK(ac)STGGK(ac)APRK(ac)QLAY],H3K4me3R2me2a [AR(me2a)TK(me3)
QTARKSTGGKAY], and H3K4me3K36me3 [ARTK(me3)
QTARKSTGGKAPRKQLATKAARKSAPATGGVK(me3)KPHRY].
Crystallization, data collection and Structure determination—Protein crystals were
grown by hanging drop vapor diffusion at 10 °C with 6 mg/ml protein in 10 mM Bis-Tris
Propane (BTP) at pH 8.0, 12 mM NaCl, 5 mM TCEP, 0.9 M ammonium sulfate and 3.5%
isopropanol. The mother liquor was 1.8 M ammonium sulfate and 7% isopropanol, and the
crystals were cryoprotected in 5 % isopropanol, 1 M ammonium sulfate and 35% ethylene
glycol. These crystals diffracted to 2.2 Å in space group I41. Native diffraction data were
collected at the APS SER-CAT 22-ID beamline and indexed with HKL2000 42. The structure
was phased using MOLREP 43 and using the human CHD1 tandem chromodomains as the
search model. The structure was built with ArpWarp 44 followed by manual model building
in Coot 45. The final structure was refined using RefMac5 restrained TLS refinement 46. All
ribbon diagrams were drawn in PyMol 47, and the structure superpositions were generated by
Coot.
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Construction of a CHD phylogenetic tree
We selected 34 unique CHD proteins in the protein sequence database. The regions of double
chromodomains were then aligned using CLUSTALW 48. This chromodomain alignment was
then used to calculate the tree by maximum likelihood method in the PHYLIP package 49.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Organization of the conserved domains within three distinct CHD proteins is compared with
the related SNF2 protein. A conserved region with the DEAXc and HELICc domains (∼450
residues) is centrally present in all these proteins, and is the ATP-dependent catalytic domain
called the SNF2 domain. The residue numbers at the beginning and end of each double
chromodomain region is listed above each diagram. Three distinct CHD classes exhibit
variability in other conserved domains as shown for CHD1, CHD4 and CHD7. The domains
are marked according to SMART nomenclature.
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The structure of yeast double chromodomains (panel A) differs from human CHD1 double
chromodomain which binds the lysine 4-methylated H3 tail (panel B). Ribbon diagrams show
same views. The coloring scheme is as follows, chromodomain 1 in cyan, chromodomain 2 in
pink, inter-chromodomain linker in grey and the inserts relative to the HP1 or Polycomb
chromodomains in yellow. The H3K4me3 peptide with sequence ARTK(me3)Q is represented
by stick drawing in black. The side chains of two key residues for methyllysine binding in
human CHD1 are drawn in stick representation in chromodomain 1 (Trp 322 and Trp 325 in
human and Trp 217 and Glu 220 in yeast). In yeast, Cys 207 and Cys 246 may assist to attach
insert 1 to α2 region via a disulfide bond. The aligned sequences of yeast double
chromodomains and human CHD1 and CHD2 are shown for chromodomain 1 (top row), the
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linker (middle row) and the chromodomain 2 (lower row). The residue numbering is arbitrary,
and secondary structure diagrams are derived from human and yeast structures.
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The chromobox 1 and 2 regions fold into highly related structures. Panel A shows the sequence
alignment of chromobox 1 and 2 segments of the representative CHD sequences from four
classes. Panel B shows a superposition of the chromobox segments from human (green) and
yeast (red) CHD1 crystal structures, showing that they arrange perpendicular to each other.
The side chains of residues 5, 8 and 10 in each chromobox are shown in stick drawing. In panel
C, fluorescence polarization binding assays are plotted to show human CHD1 binds specifically
to the H3K4me3 peptide, whereas human CHD2 binds non-specifically and E220W mutant of
yeast CHD1 does not interact with the H3K4me3 peptide.
Flanagan et al. Page 13














A phylogenetic tree constructed using the double chromodomain regions of non-redundant
CHD sequences. Four major divisions are highlighted to suggest unique double chromodomain
branches. Not highlighted are the four CHD proteins which exhibit significant divergence in
their sequences.
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Table 1




 a, b, c (Å) 136.185, 136.185,
57.516
 α, β, γ (°) 90, 90, 90
Resolution (Å) 19.57(2.2)*

















 Bond lengths (Å) 0.023
 Bond angles (°) 2.23
*
Highest resolution shell is shown in parenthesis.
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